CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Kowa Company, Ltd. v. Hetero Drugs Limited

1:17-cv-00762

Overview

Case Number 1:17-cv-00762
Filing Date 2017-06-14
Status Terminated
Termination Date 2018-10-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Hetero Labs Limited Unit-V NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Hetero Drugs Limited NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Kowa Company, Ltd. Operating Company

Represented By

2 Attorneys Listed

Denise Seastone Kraft

Barnard, Mezzanotte, Pinnie, Seelaus & Kraft, LLP

Tel: +1 (302) 594-4535
Fax: +1 (610) 565-3309

1205 N. Orange Street, Wilmington, DE 19801

Brian A. Biggs

DLA Piper LLP

Tel: +1 (302) 468-5661

1201 N. Market Street, Suite 2100, Wilmington, DE 19801

Counter Claimant

Hetero Labs Limited NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Hetero USA Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Counter Defendant

Nissan Chemical Industries, Ltd. Operating Company

Represented By

2 Attorneys Listed

Denise Seastone Kraft

Barnard, Mezzanotte, Pinnie, Seelaus & Kraft, LLP

Tel: +1 (302) 594-4535
Fax: +1 (610) 565-3309

1205 N. Orange Street, Wilmington, DE 19801

Brian A. Biggs

DLA Piper LLP

Tel: +1 (302) 468-5661

1201 N. Market Street, Suite 2100, Wilmington, DE 19801

Kowa Pharmaceuticals America, Inc. Operating Company

Represented By

2 Attorneys Listed

Denise Seastone Kraft

Barnard, Mezzanotte, Pinnie, Seelaus & Kraft, LLP

Tel: +1 (302) 594-4535
Fax: +1 (610) 565-3309

1205 N. Orange Street, Wilmington, DE 19801

Brian A. Biggs

DLA Piper LLP

Tel: +1 (302) 468-5661

1201 N. Market Street, Suite 2100, Wilmington, DE 19801

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 17 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (17): πŸ‡ͺπŸ‡Ί Europe πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8557993
Crystalline forms of pitavastatin calcium
Filed: 2012-10-31
Issued: 2013-10-15
Active (5.9 yrs remaining)
Expires: 2032-10-31

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Docket Entries

(14 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2163067.) - filed by Kowa Pharmaceuticals America, Inc., Kowa Company, Ltd., Nissan Chemical Industries, Ltd.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sar) (Entered: 06/15/2017)

Entry #1 • 2017-06-14
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 06/15/2017)

Entry #2 • 2017-06-14
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/2/17. Date of Expiration of Patent: 2/2/24.Thirty Month Stay Deadline: 11/2/2019. (sar) (Entered: 06/15/2017)

Entry #3 • 2017-06-14
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,557,993;. (sar) (Entered: 06/15/2017)

Entry #4 • 2017-06-14
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Kowa Company, Ltd. for Kowa Pharmaceuticals America, Inc. filed by Kowa Company, Ltd., Kowa Pharmaceuticals America, Inc., Nissan Chemical Industries, Ltd.. (sar) (Entered: 06/15/2017)

Entry #5 • 2017-06-14
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc